EA
TMCI icon

Emerald Advisers’s Treace Medical Concepts TMCI Stock Holding History

Emerald Advisers’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,561,893
Closed -$20.4M – 270
2024
Q1 		$20.4M Buy
1,561,893
+114,304
+8% +$1.52M 0.82% 49
2023
Q4 		$18.5M Sell
1,447,589
-25,692
-2% -$260K 0.79% 52
2023
Q3 		$19.3M Buy
1,473,281
+107,143
+8% +$1.96M 0.94% 41
2023
Q2 		$34.9M Buy
1,366,138
+2,685
+0.2% +$69.3K 1.53% 8
2023
Q1 		$34.3M Buy
1,363,453
+175,207
+15% +$4.11M 1.65% 7
2022
Q4 		$27.3M Buy
1,188,246
+67,481
+6% +$1.55M 1.32% 20
2022
Q3 		$24.7M Buy
1,120,765
+51,881
+5% +$1M 1.28% 22
2022
Q2 		$15.3M Buy
1,068,884
+196,605
+23% +$3.31M 0.79% 50
2022
Q1 		$16.5M Buy
872,279
+493,351
+130% +$9.59M 0.63% 66
2021
Q4 		$7.06M Buy
378,928
+107,051
+39% +$2.21M 0.26% 109
2021
Q3 		$7.31M Buy
271,877
+1,470
+0.5% +$40.4K 0.27% 108
2021
Q2 		$8.45M Buy
+270,407
New +$8.61M 0.31% 107

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Emerald Advisers's TMCI Position: Q2 2024 in Review

Emerald Advisers sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 1,561,893 shares — an estimated $20.4M sold.

Emerald Advisers first reported a position in TMCI in Q2 2021 and held it in 12 quarters. The position peaked at $34.9M in Q2 2023. 128 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Emerald Advisers reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • Emerald Advisers sold 1,561,893 Treace Medical Concepts shares in Q2 2024, an estimated $20.4M.
  • Emerald Advisers first reported a position in Treace Medical Concepts in Q2 2021 and held it in 12 quarters.
  • Emerald Advisers's Treace Medical Concepts position peaked at $34.9M in Q2 2023.
  • 128 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Emerald Advisers's 13F filing for Q2 2024, filed 6 Aug 2024.